Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-11

Clinical Trial Update: A Study of IXAZOMIB in Adult Patients With Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of ixazomib in adult patients with lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ixazomib (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2015-11-11